Cargando…

N-myristoyltransferase: A potential novel diagnostic marker for colon cancer

BACKGROUND: Colon cancer is the second leading cause of cancer deaths in the western world. If detected early, colorectal cancer is one of the most treatable forms of cancer. Unfortunately, very few people are screened. N-myristoyltransferase (NMT) catalyzes myristoylation of various proteins includ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shrivastav, Anuraag, Varma, Shailly, Saxena, Anurag, DeCoteau, John, Sharma, Rajendra K
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2203986/ https://www.ncbi.nlm.nih.gov/pubmed/18021392 http://dx.doi.org/10.1186/1479-5876-5-58

Ejemplares similares

Investigation of Novel Regulation of N-myristoyltransferase by Mammalian Target of Rapamycin in Breast Cancer Cells
por: Jacquier, Marine, et al.
Publicado: (2018)

In silico identification of microRNAs predicted to regulate N-myristoyltransferase and Methionine Aminopeptidase 2 functions in cancer and infectious diseases
por: Chauhan, Ranjit, et al.
Publicado: (2018)

N-myristoyltransferase 2–based Blood Test for the Detection of Colorectal Adenomatous Polyps and Cancer
por: Rathinagopal, Tharmini, et al.
Publicado: (2022)

Expression and activity of N-myristoyltransferase in lung inflammation of cattle and its role in neutrophil apoptosis
por: Shrivastav, Anuraag, et al.
Publicado: (2009)

The Potential Use of N-Myristoyltransferase as a Biomarker in the Early Diagnosis of Colon Cancer
por: Kumar, Sujeet, et al.
Publicado: (2011)

Insulin-Like Growth Factor Binding Protein-3 (IGFBP-3): Unraveling the Role in Mediating IGF-Independent Effects Within the Cell
por: Varma Shrivastav, Shailly, et al.
Publicado: (2020)

Insulin-Like Growth Factor Binding Protein-3 Binds to Histone 3
por: Bhardwaj, Apurva, et al.
Publicado: (2021)

N-Terminal Region of the Catalytic Domain of Human N-Myristoyltransferase 1 Acts as an Inhibitory Module
por: Kumar, Sujeet, et al.
Publicado: (2015)

Biochemical Characterization of Bovine Brain Myristoyl-CoA:Protein N-Myristoyltransferase Type 2
por: Selvakumar, Ponniah, et al.
Publicado: (2009)

Myristoylation: An Important Protein Modification in the Immune Response
por: Udenwobele, Daniel Ikenna, et al.
Publicado: (2017)

The role of N-myristoyltransferase 1 in tumour development
por: Wang, Hong, et al.
Publicado: (2023)

Novel Hits for N-Myristoyltransferase Inhibition Discovered by Docking-Based Screening
por: Spassov, Danislav S., et al.
Publicado: (2022)

N-Myristoyltransferase, a Potential Antifungal Candidate Drug-Target for Aspergillus flavus
por: Wang, Yu, et al.
Publicado: (2022)

Biochemical and genetic characterization of Trypanosoma cruzi N-myristoyltransferase
por: Roberts, Adam J., et al.
Publicado: (2014)

QSAR Study of N-Myristoyltransferase Inhibitors of Antimalarial Agents
por: Santos-Garcia, Letícia, et al.
Publicado: (2018)

Validation and Invalidation of Chemical Probes for the Human N-myristoyltransferases
por: Kallemeijn, Wouter W., et al.
Publicado: (2019)

Discovery of a Novel Class of Orally Active Trypanocidal N-Myristoyltransferase Inhibitors
por: Brand, Stephen, et al.
Publicado: (2011)

Exploring Novel N-Myristoyltransferase Inhibitors: A Molecular Dynamics Simulation Approach
por: Khalil, Ruqaiya, et al.
Publicado: (2019)

Novel Thienopyrimidine Inhibitors of Leishmania N-Myristoyltransferase with On-Target Activity in Intracellular Amastigotes
por: Bell, Andrew S., et al.
Publicado: (2020)

Chaetocin antileukemia activity against chronic myelogenous leukemia cells is potentiated by bone marrow stromal factors and overcomes innate imatinib resistance
por: Truitt, L, et al.
Publicado: (2014)

Validation of N-myristoyltransferase as Potential Chemotherapeutic Target in Mammal-Dwelling Stages of Trypanosoma cruzi
por: Herrera, Linda J., et al.
Publicado: (2016)

N-Myristoyltransferase inhibitors as new leads to treat sleeping sickness
por: Frearson, Julie A., et al.
Publicado: (2010)

Discovery of high affinity inhibitors of Leishmania donovani N-myristoyltransferase
por: Rackham, Mark D., et al.
Publicado: (2015)

Discovery of pyridyl-based inhibitors of Plasmodium falciparum N-myristoyltransferase
por: Yu, Zhiyong, et al.
Publicado: (2015)

N-Myristoyltransferase Is a Cell Wall Target in Aspergillus fumigatus
por: Fang, Wenxia, et al.
Publicado: (2015)

Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors
por: Bayliss, Tracy, et al.
Publicado: (2017)

Structure-guided optimization of quinoline inhibitors of Plasmodium N-myristoyltransferase
por: Goncalves, Victor, et al.
Publicado: (2016)

Inhibition of N‐myristoyltransferase1 affects dengue virus replication
por: Suwanmanee, San, et al.
Publicado: (2019)

Inhibitor Trapping in N-Myristoyltransferases as a Mechanism for Drug Potency
por: Spassov, Danislav S., et al.
Publicado: (2023)

Discovery of Novel and Ligand-Efficient Inhibitors of Plasmodium falciparum and Plasmodium vivaxN-Myristoyltransferase
por: Rackham, Mark D., et al.
Publicado: (2012)

Analyzing a Potential Drug Target N-Myristoyltransferase of Plasmodium falciparum Through In Silico Approaches
por: Banerjee, Amit Kumar, et al.
Publicado: (2012)

Structure-Based Design of Potent and Selective LeishmaniaN-Myristoyltransferase Inhibitors
por: Hutton, Jennie A., et al.
Publicado: (2014)

Peptidomimetic inhibitors of N-myristoyltransferase from human malaria and leishmaniasis parasites
por: Olaleye, Tayo O., et al.
Publicado: (2014)

Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase
por: Robinson, David A., et al.
Publicado: (2015)

Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani
por: Corpas-Lopez, Victoriano, et al.
Publicado: (2018)

Structure-Guided Identification of Resistance Breaking Antimalarial N‑Myristoyltransferase Inhibitors
por: Schlott, Anja C., et al.
Publicado: (2019)

Diverse modes of binding in structures of Leishmania major N-myristoyltransferase with selective inhibitors
por: Brannigan, James A., et al.
Publicado: (2014)

Whole Proteome Profiling of N-Myristoyltransferase Activity and Inhibition Using Sortase A
por: Goya Grocin, Andrea, et al.
Publicado: (2019)

N-myristoyltransferase deficiency impairs AMPK activation and promotes synovial tissue inflammation
por: Wen, Zhenke, et al.
Publicado: (2019)

Binding Affinity Determines Substrate Specificity and Enables Discovery of Substrates for N-Myristoyltransferases
por: Su, Dan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nu6b6g5cajuu5ptaiqsvuba4gk